Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia
Authors
Keywords
-
Journal
Biomolecules
Volume 12, Issue 1, Pages 108
Publisher
MDPI AG
Online
2022-01-11
DOI
10.3390/biom12010108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
- (2021) Cássio Morais Loss et al. Frontiers in Pharmacology
- Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice
- (2021) Valentina Chiodi et al. FASEB JOURNAL
- Binge-like Alcohol Exposure in Adolescence: Behavioural, Neuroendocrine and Molecular Evidence of Abnormal Neuroplasticity… and Return
- (2021) Anna Brancato et al. Biomedicines
- Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
- (2021) Tibor Stark et al. PHARMACOLOGICAL RESEARCH
- Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects
- (2021) Marco Raffaele et al. GeroScience
- Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment
- (2020) Tibor Stark et al. BIOCHEMICAL PHARMACOLOGY
- Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
- (2020) Thomas Murphy et al. Biomolecules
- Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
- (2020) Martina Di Bartolomeo et al. PHARMACOLOGICAL RESEARCH
- Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue
- (2020) Jan Kucera et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice
- (2019) Vincenzo Micale et al. Frontiers in Pharmacology
- Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats
- (2019) Eva Drazanova et al. Scientific Reports
- The importance of sex differences in pharmacology research
- (2019) Andrea Gogos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neurodevelopment and behavior in neonatal OXYS rats with genetically determined accelerated senescence
- (2018) Tatyana N. Igonina et al. BRAIN RESEARCH
- Endocannabinoid system, Stress and HPA axis
- (2018) Vincenzo Micale et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function
- (2018) Kleanthi Chalkiadaki et al. NEUROPHARMACOLOGY
- Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats
- (2018) Libor Uttl et al. Frontiers in Neuroscience
- Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
- (2018) Tibor Stark et al. NEUROPHARMACOLOGY
- HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals
- (2017) Josef Večeřa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia
- (2017) Yelena Gulchina et al. JOURNAL OF NEUROCHEMISTRY
- Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus
- (2017) Vincenzo Micale et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?
- (2017) Renata Androvicova et al. PHARMACOLOGICAL RESEARCH
- A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
- (2017) Claudio D'Addario et al. SCHIZOPHRENIA RESEARCH
- Neurodevelopmental Reflex Testing in Neonatal Rat Pups
- (2017) Antoinette T. Nguyen et al. Jove-Journal of Visualized Experiments
- The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801
- (2016) Marta Kruk-Slomka et al. NEUROTOXICITY RESEARCH
- Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
- (2016) Fabio Arturo Iannotti et al. PROGRESS IN LIPID RESEARCH
- Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats
- (2016) Jana Ruda-Kucerova et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats
- (2015) Jana Ruda-Kucerova et al. Frontiers in Psychiatry
- Immunocytochemical markers of neuronal maturation in human diagnostic neuropathology
- (2014) Harvey B. Sarnat CELL AND TISSUE RESEARCH
- Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice
- (2014) Ana Luisa B. Terzian et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Leading compounds for the validation of animal models of psychopathology
- (2013) Vincenzo Micale et al. CELL AND TISSUE RESEARCH
- Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial
- (2013) Sergi Mas et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
- (2013) E M P Poels et al. MOLECULAR PSYCHIATRY
- Phencyclidine-Induced Social Withdrawal Results from Deficient Stimulation of Cannabinoid CB1 Receptors: Implications for Schizophrenia
- (2013) Alexandre Seillier et al. NEUROPSYCHOPHARMACOLOGY
- Chronic blockade of CB1receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation
- (2012) E Zamberletti et al. BRITISH JOURNAL OF PHARMACOLOGY
- The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats
- (2012) Alessandra Tamburella et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neurodevelopmental model of schizophrenia: update 2012
- (2012) J L Rapoport et al. MOLECULAR PSYCHIATRY
- DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses
- (2012) Ku-Lung Hsu et al. Nature Chemical Biology
- Endocannabinoid system: Potential novel targets for treatment of schizophrenia
- (2012) Atsushi Saito et al. NEUROBIOLOGY OF DISEASE
- Gestational Methylazoxymethanol Exposure Leads to NMDAR Dysfunction in Hippocampus During Early Development and Lasting Deficits in Learning
- (2012) Melissa A Snyder et al. NEUROPSYCHOPHARMACOLOGY
- Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model
- (2012) Stephan Direnberger et al. Nature Communications
- The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications
- (2011) MP Viveros et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the Hippocampus
- (2011) Eva Hradetzky et al. NEUROPSYCHOPHARMACOLOGY
- Selective Remediation of Reversal Learning Deficits in the Neurodevelopmental MAM Model of Schizophrenia by a Novel mGlu5 Positive Allosteric Modulator
- (2011) Francois Gastambide et al. NEUROPSYCHOPHARMACOLOGY
- Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects
- (2011) Johannes Rentzsch et al. SCHIZOPHRENIA RESEARCH
- The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
- (2011) Ana Luisa Terzian et al. Frontiers in Behavioral Neuroscience
- Sexually Dimorphic Effects of Cannabinoid Compounds on Emotion and Cognition
- (2011) Tiziana Rubino et al. Frontiers in Behavioral Neuroscience
- How important are sex differences in cannabinoid action?
- (2010) Liana Fattore et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine
- (2010) Cinzia Guidali et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Prolonged fear incubation leads to generalized avoidance behavior in mice
- (2010) F.A. Pamplona et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neonatal Behavioral Changes in Rats With Gestational Exposure to Lipopolysaccharide: A Prenatal Infection Model for Developmental Neuropsychiatric Disorders
- (2010) M. Baharnoori et al. SCHIZOPHRENIA BULLETIN
- Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia
- (2009) Daniel J. Lodge et al. BEHAVIOURAL BRAIN RESEARCH
- Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
- (2009) Alexandre Seillier et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia
- (2009) Jared W. Young et al. PHARMACOLOGY & THERAPEUTICS
- Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: Behavioral and neurochemical studies in rats
- (2009) Alessandra Tamburella et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Modelling prefrontal cortex deficits in schizophrenia: implications for treatment
- (2008) J A Pratt et al. BRITISH JOURNAL OF PHARMACOLOGY
- Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: A possible role for the endocannabinoid system
- (2008) Ricardo Llorente et al. Developmental Neurobiology
- Early detection and intervention of psychosis. A review
- (2008) Raimo K.R. Salokangas et al. NORDIC JOURNAL OF PSYCHIATRY
- Physical Manifestations of Neurodevelopmental Disruption: Are Minor Physical Anomalies Part of the Syndrome of Schizophrenia?
- (2008) M. T. Compton et al. SCHIZOPHRENIA BULLETIN
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now